Your browser doesn't support javascript.
loading
Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway.
Xiao, Lan; Shi, Xiao Yan; Li, Ze Lian; Li, Min; Zhang, Min Min; Yan, Shi Jie; Wei, Zhao Lian.
Afiliação
  • Xiao L; Department of Obstetrics & Gynecology, the First Affiliated Hospital, Anhui Medical University, Hefei, China.
  • Shi XY; Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li ZL; Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li M; Department of Obstetrics & Gynecology, the First Affiliated Hospital, Anhui Medical University, Hefei, China.
  • Zhang MM; Department of Obstetrics & Gynecology, the First Affiliated Hospital, Anhui Medical University, Hefei, China.
  • Yan SJ; Department of Obstetrics & Gynecology, the First Affiliated Hospital, Anhui Medical University, Hefei, China.
  • Wei ZL; Department of Obstetrics & Gynecology, the First Affiliated Hospital, Anhui Medical University, Hefei, China.
J Gynecol Oncol ; 32(5): e77, 2021 09.
Article em En | MEDLINE | ID: mdl-34132072
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cisplatino / Resistencia a Medicamentos Antineoplásicos / RNA Longo não Codificante Limite: Female / Humans Idioma: En Revista: J Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cisplatino / Resistencia a Medicamentos Antineoplásicos / RNA Longo não Codificante Limite: Female / Humans Idioma: En Revista: J Gynecol Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China